Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Roche Claims 'Other Options' If Illumina Deal Fails

Roche Claims 'Other Options' If Illumina Deal Fails

Mar 06, 2012

NEW YORK (GenomeWeb News) – Roche Chairman Franz Humer today said that the firm has "other options" if its bid to acquire Illumina fails.

Humer's statement was part of prepared remarks made for Roche's annual general meeting, held today in Basel, Switzerland, where the firm is based.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Quick Changes If Needed

Moderna says it would be able to quickly update its SARS-CoV-2 vaccine to address new genetic variants if needed, MIT's Technology Review reports.

Early Results on Johnson & Johnson's SARS-CoV-2 Vaccine

Johnson & Johnson reports interim results from a Phase 1/2 study of its SARS-CoV-2 vaccine in the New England Journal of Medicine, according to Bloomberg.

WHO Team Arrives

Investigators from the World Health Organization have arrived in China to look into the origins of SARS-CoV-2, NPR reports.

Nature Papers Present Amplicon Sequencing Approach, Dire Wolf Genomes

In Nature this week: a new method for high-throughput amplicon sequencing, and more.

Feb
24
Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. 

What's Popular?

In Clinical Sequencing

  1. JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More

  2. Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan

  3. Pacific Biosciences, Invitae to Develop Clinical Whole-Genome Sequencing Platform

  4. Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan

  5. PGDx, Qiagen Partner on Clinical Decision Support for Molecular Cancer Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.